Quality Systems – Page 260

Pet Failure during bulk hold: GMP investigation steps with CAPA

Steps for Investigating Pet Failure During Bulk Hold in Pharmaceutical Manufacturing In the realm of pharmaceutical manufacturing, encountering a Pet failure during bulk hold can lead to significant challenges, impacting…

Preservative Miscalculation after supplier change: investigation steps with CAPA evidence

Addressing Preservative Miscalculation Following a Supplier Change: A Detailed Investigation Guide In the complex world of pharmaceutical manufacturing, a preservative miscalculation can lead to significant quality control challenges, especially after…

Fill Weight Variability in dental gel manufacturing: QMS trending and complaint handling expectations

Addressing Fill Weight Variability Issues in Dental Gel Production: A Structured Investigation Approach Fill weight variability in dental gel manufacturing is a critical issue that can lead to non-compliance with…

Texture Grittiness Complaint during bulk hold: sampling and mixing controls for QA review

Investigating Texture Grittiness Complaints during Bulk Hold: Sampling and Mixing Controls for QA Review In pharmaceutical manufacturing, quality complaints can significantly impact production schedules and product integrity. One ongoing challenge…

Texture Grittiness Complaint after packaging change: GMP investigation steps with CAPA

GMP Investigation Steps for Texture Grittiness Complaints Following Packaging Changes In pharmaceutical manufacturing, changes in packaging can inadvertently lead to unexpected product quality issues, such as texture grittiness. Such complaints…

Sedimentation Oos during line setup: packaging integrity and stability justification

Addressing Sedimentation OOS During Line Setup: Ensuring Packaging Integrity and Stability The occurrence of Out of Specification (OOS) results during the setup of a line can considerably impact the efficiency…

E&L Failure in dental gel manufacturing: QMS trending and complaint handling expectations

E&L Failure in Dental Gel Manufacturing: Investigating Quality Management Trends and Complaint Handling In the pharmaceutical manufacturing landscape, particularly in dental gel production, extractables and leachables (E&L) failures pose significant…

Content Uniformity Failure after supplier change: manufacturing vs lab root cause assessment

Root Cause Assessment of Content Uniformity Failures Following Supplier Changes In the pharmaceutical industry, ensuring content uniformity is critical for the regulatory compliance, safety, and efficacy of dosage forms. A…

Hold Time Bioburden Rise in otic suspension filling: packaging integrity and stability justification

Investigation of Hold Time Bioburden Rise in Otic Suspension Filling In the highly regulated environment of pharmaceutical manufacturing, the integrity of sterile products must be meticulously controlled. A recent incident…

Assay Oos during inspection readiness: QMS trending and complaint handling expectations

Investigating Assay OOS: Managing Compliance and Complaint Handling in Pharmaceutical Inspections During the manufacturing process of dental dosage forms, unexpected Out of Specification (OOS) results can arise, particularly concerning assay…

Texture Grittiness Complaint in dental gel manufacturing: manufacturing vs lab root cause assessment

Assessing Grittiness Complaints: Differentiating Between Manufacturing and Lab Root Causes in Dental Gel Production In pharmaceutical manufacturing, particularly within the dental gel segment, complaints regarding texture grittiness can pose serious…

Texture Grittiness Complaint during method transfer: packaging compatibility and shelf-life justification

Investigating Texture Grittiness Complaints During Method Transfer in Pharmaceutical Manufacturing In the highly regulated world of pharmaceutical manufacturing, texture complaints, such as grittiness, can pose significant challenges, particularly during method…